Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by Camaronion Nov 16, 2011 3:15pm

239 Views

Post# 19242665

TD CanadaTrust Calculates Bk/Val @ $0.93

Hey The 300, Against this Bk/Val seems unusually low shr price and once that is intentially being held back in the way I described. Can't be just due to lack of interst when it can be baought for this far below book is my thought. Makes me curiouser and curiouser. Thanks for your comments though.Per Share Data Industry Range HLO IndustryEarnings (TTM) -4.5 74.0 -- $2.32Book Value -7.3 75.4
.93 $13.31Cash Flow (TTM) -- -- -- -

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario